A ceremony marking the start of construction on AstraZeneca's new small molecule drug factory is held in Wuxi, East China's Jiangsu province, on May 8. [Photo provided to chinadaily.com.cn] ...

Last week, readers were most interested in a story about what's up Roche's sleeve as it talked about its plans during its investor day.

Digital Pathology–Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer FGFR2b protein ...

Danaher, a US-headquartered life sciences conglomerate, unveils QPix FLEX Microbial Colony Picker, a Shanghai-developed and produced product, on May 14. [Photo by Gu Yingjie/chinadaily.com.cn] ...

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient ...

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

The companies will develop and commercialize diagnostic tools to help clinicians determine which patients would benefit from precision medicine treatments.

Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for precision medicine treatments, including artificial intelligence ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

Danaher and AstraZeneca have formed a partnership to develop diagnostic tools that help clinicians better determine which patients would benefit from precision medicine treatments.

According to the National Institutes of Health, in the United States, it's estimated that over 2 million people are affected by aphasia, a language disorder. In recognition of Aphasia Awareness Month, ...

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") , which subsidiary is listed on the Main Board of The Stock ...